SCHEMBL7780001

SCHEMBL7780001

NS(=O)(=O)c1ccc(-c2n[nH]c(C(F)(F)Cl)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.51
GYS1 P13807 1/20 0.46
PTGS2 P35354 10/20 0.46
PTGS1 P23219 7/20 0.46
TTK P33981 1/20 0.46
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
CA12 O43570 2/20 0.45
CA4 P22748 2/20 0.45
CA5A P35218 2/20 0.45
CA5B Q9Y2D0 2/20 0.45
CA3 P07451 1/20 0.45
CA6 P23280 1/20 0.45
CA7 P43166 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
CA14 Q9ULX7 1/20 0.45
MAP2K7 O14733 1/20 0.44
MAP2K4 P45985 1/20 0.44
MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779654 0.91 LRRK2 (0.60) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7780727 0.89 LRRK2 (0.50) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7773229 0.89 LRRK2 (0.50) LRRK2PTGS2PTGS1TTKCA1
SCHEMBL7778131 0.88 PTGS2 (0.50) LRRK2GYS1PTGS2PTGS1
SCHEMBL8631595 0.81 GYS1 (0.48) LRRK2GYS1PTGS2PTGS1CA1
SCHEMBL7773014 0.80 LRRK2 (0.61) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7773326 0.80 LRRK2 (0.68) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7780738 0.79 LRRK2 (0.60) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7778049 0.79 LRRK2 (0.64) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7772883 0.79 PTGS2 (0.47) LRRK2PTGS2PTGS1TTKCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed